Search
SOLACI Congress
Day 1

Hemoducto Venoso: Cambio en el Paradigma de Tratamiento

solaci
solaci
296
0

12_pichard_augusto2
Augusto Pichard
2014-08-07

Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, 
Medstar Washington Hospital Center. Professor of Medicine (Cardiology),
Georgetown University Medical School.

Previous article
Qué mas que la Angiografía es Necesario para Optimizar mis Resultados?
Next article
Chronic Total Occlusions
solaci
solaci

More articles by this author

Nuevas Estrategias de Reperfusión Miocárdica en el IAM con Elevación del Segmento ST

solaci - 0
José Mangione2014-08-07

Prevención y Manejo de dificultades en la via radial

solaci - 0
Pablo Vázquez Grenno 2014-08-07Sanatorio Americano. CCAMontevideo. Uruguay

Caso Clinico

solaci - 0
Alfaro Marchena Noriega2014-08-07Vicepresidente Sociedad Panameña de CardiologíaPresidente Fundación Cardiológica de Panamá

Chronic Total Occlusions

solaci - 0
Luis A Guzman2014-08-07Director, Cardiovascular InterventionsUniversity of Florida-Jacksonville

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Dr. Omar Tupayachi - 0
Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Dr. Omar Tupayachi - 0
Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy